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Abstract
We report the atomic resolution (1.3 Å) X-ray crystal structure of the open conformation
of the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE, E.C. 3.5.1.18)
from Neisseria meningitdis. This structure (PDB 5UEJ) contains two bound sulfate ions in the
active site that mimic the binding of the terminal carboxylates of the N-succinyl-L,Ldiaminopimelic acid (L,L-SDAP) substrate. We demonstrated inhibition of DapE by sulfate
(IC50 = 13.8 ± 2.8 mM). Comparison with other DapE structures in the PDB demonstrates the
flexibility of the inter-domain connections of this protein. This high-resolution structure was
then utilized as the starting point for targeted molecular dynamics experiments revealing the

conformational change from the open form to the closed form that occurs when DapE binds L,LSDAP and cleaves the amide bond. These simulations demonstrated closure from the open to the
closed conformation, the change in RMS throughout the closure, and the independence in the
movement of the two DapE subunits. Although there was no targeting force, the substrate
moved closer to the active site and bound more tightly during the closure event.

Introduction
The rapid rise in morbidity and mortality from bacterial infections caused by antibioticresistant bacteria1 underlines the need to discover antibiotics with a new mechanism of action by
targeting previously unexplored bacterial enzymes. For example, invasive methicillin-resistant
Staphylococcus aureus (MRSA) is a serious and growing health problem.2 Several newly
discovered strains of MRSA show antibiotic resistance even to vancomycin, which is considered
a last resort for the treatment of systemic infections.3 An attractive but underexplored bacterial
target that is present in all Gram-negative and most Gram-positive bacteria is the dapE-encoded
N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE, E.C. 3.5.1.18).4 DapE is a member of
the lysine biosynthetic pathway in bacteria that is responsible for the synthesis of lysine and
meso-diaminopimelate (m-DAP),5 both of which are critical for peptidoglycan cell-wall
synthesis. DapE enzymes catalyze the hydrolysis of N-succinyl-L,L-diaminopimelic acid (L,LSDAP) to succinate and L,L-diaminopimelic acid (L,L-DAP, Figure 1).

Figure 1. Hydrolysis of L,L-SDAP by DapE. L,L-SDAP (1a) and assay substrate N6-methylL,L-SDAP6 (1b) with formation of hydrolysis products succinate (2) and L,L-diaminopimelic acid derivatives 3a
and 3b, respectively.

Deletion of the dapE gene is lethal to Helicobacter pylori and Mycobacterium smegmatis,
demonstrating the indispensable role of this enzyme in bacterial survival, and therefore
pathogenesis in the human host.7, 8 Furthermore, lack of a similar pathway in humans suggests
that inhibition of DapE should be selectively toxic to bacteria but not human hosts, making it a
promising target for antibiotics with a new mechanism of action free of mechanism-based side
effects.4 To conveniently measure the inhibitory potency of test compounds versus DapE, we
previously reported a ninhydrin-based assay6 employing the substrate N6-methyl-L,L-SDAP (1b),
which when cleaved by DapE affords the primary amine product 3b (Fig. 1) that can be
quantified spectrophotometrically after treatment with ninhydrin.
The first X-ray crystal structure of an apo DapE from Neisseria meningitidis (NmDapE)
was solved in 2005,9 and was followed by structures of mono- and di-Zn forms from
Haemophilus influenzae (HiDapE)10 and mono- and di-Zn forms from NmDapE.11 Significantly,
the structure of the DapE inhibitor captopril bound to the active site demonstrated interactions of
the thiol moiety with the active site zinc atoms.11 We recently reported a DapE crystal structure
revealing the previously-unknown closed conformation of dimeric DapE with the products of
enzymatic cleavage, succinate and diaminopimelic acid, bound in the active site (PDB 5VO3).12
This structure also revealed the role of His195B, a residue on the opposite subunit that moves
~10 Å and provides a key H-bond to the substrate in the active site.12 The requirement of this

His residue explains the observed inactivity of a truncated, monomeric construct of DapE.6 The
products bound structure, aided by our products-bound transition state modeling (PBTSM)
approach,12, 13 enabled further refinement of the proposed reaction mechanism of DapE that will
facilitate inhibitor identification14-16 for the discovery of new antibiotics that inhibit DapE.
We report herein a new atomic-resolution (1.3 Å) X-ray crystal structure of NmDapE
(PDB 5UEJ) with sulfate ions bound in the substrate recognition pocket. Our previous closed
products-bound structure of HiDapE12 in combination with this new high-resolution open
structure further defines the dramatic conformational range of motion that occurs for DapE
during its catalytic cycle and enabled us to explore this remarkable conformational process using
targeted molecular dynamics (TMD).

Experimental
Protein Preparation and Crystallization
NmDapE was expressed in E. coli and prepared according to a protocol described
previously.6, 11, 12 Bacteria were cultured with shaking at 210 rpm in LB medium supplemented
with 150 μg/ml ampicillin at 37°C until the OD600 reached 1.0. The temperature was lowered to
18°C and isopropyl-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.5
mM. The culture was grown for 18 h and then centrifuged at 4500 rpm for 10 min at 4°C. The
cell pellet derived from 1 L of culture was resuspended in 35 mL of lysis buffer (50 mM HEPES
sodium salt pH 8.0, 500 mM NaCl, 5% glycerol, 20 mM imidazole, 10 mM β-mercaptoethanol)
and stored at -80°C. The samples were thawed and the cells were disrupted by sonication using
bursts totaling 5 min in duration, with appropriate intervals for cooling. The cell debris was then
pelleted by centrifugation at 15,000 rpm for 30 min at 4°C. The supernatant was applied to a

column packed with 10 mL of HisTrap HP resin (GE Healthcare), connected to a VacMan
(Promega) and the chromatographic process was accelerated with a vacuum pump. The column
was washed with 20 bed volumes of lysis buffer, and the His6-tagged P5CRs were eluted with 25
mL of elution buffer (50 mM HEPES pH 8.0, 500 mM NaCl; 500 mM imidazole; 2 mM DTT).
The His6-tag was cleaved with TEV protease (2 mg of a His6-tagged form) overnight at 4°C, and
dialysis to remove the excess imidazole was carried out simultaneously. The resulting solution
was mixed with His-Trap HP resin to capture the cleaved His6-tag and the His6-tagged TEV
protease with the flow through containing the DapE protein, which was collected and
concentrated. The next step required running the sample through a HiLoad 16/600 Superdex 200
Prep Grade column and eluting with the crystallization buffer.
Crystal Structure of NmDapE at 1.3 Å Resolution
Crystals were grown using freshly purified protein (~20 mg/ml) by the sitting drop
method at 17 °C employing a precipitant solution of 0.2 M Li2SO4, 0.1 M Tris (pH 8.5), 1.26 M
(NH4)2SO4 and 0.05 M DMSO over several weeks. The crystals belonged to the P212121 space
group with unit cell parameters of a = 74.8 Å, b = 88.6Å, c = 133.4 Å and α = β = γ = 90° with a
single dimer in the asymmetric unit (Table S1), consistent with NmDapE in solution, which is a
dimer. Prior to data collection, the mother liquor containing 25% glycerol was used as a
cryoprotectant. A single crystal was picked up with a MiTeGen loop and flash-frozen in liquid
nitrogen. The data set was collected at the 19-ID17 beamline of the Structural Biology Center at
the Advanced Photon Source, Argonne National Laboratory. All data sets were processed using
the HKL300018 suite of programs. Data collection statistics are presented in Table S1. The highresolution crystal structure of DapE was determined using the molecular replacing method
employing the program MolRep19 using the previously determined structure of NmDapE. Cycles

of manual corrections of the model were carried out in the program COOT,20 and the refinement
routine was implemented in the program Refmac.fva.21 The crystals diffracted to near atomic
resolution, 1.30 Å, compared to the best resolution previously obtained for a DapE structure of
1.80 Å. This improvement in resolution allowed us to refine the structure anisotropically and to
determine more detailed and accurate positions of atoms, reliable recognition of alternative
conformations, and the correct positions of hydrogen atoms. This in turn enables more accurate
docking and molecular dynamics studies that will ultimately enhance inhibitor design. The
model of the structure has Rwork/Rfree = 11/15%. Analysis and validation of the structure was
performed with the aid of MOLPROBITY and COOT validation tools.22, 23 Figures were
prepared using VMD.24 The atomic coordinates and the structure factor file for this new open
form of NmDapE have been deposited in the RCSB Protein Bank with accession code 5UEJ.
Enzyme assays
DapE Enzyme Inhibition by Sulfate: IC50 determination
The inhibition of HiDapE by sulfate was assessed using lithium sulfate following the
protocol detailed by us previously6 with slight modifications as detailed below. All inhibition
assays were conducted with a reaction volume of 200 μL, 2 mM N6-methyl-L,L-SDAP and 8 nM
HiDapE. To a 50 mM HEPES, pH 7.5 buffered solution at 0 °C was added lithium sulfate
followed by HiDapE and incubated for 10 min. N6-Methyl-L,L-SDAP was added and allowed to
react for 10 min followed by heating to 100 °C for 1 min and cooled on ice to 0 °C. A 2%
ninhydrin solution (100 µL) was added, and the mixture was vortexed. The reaction was heated
to 80 °C for 15 min followed by cooling on ice. The absorbance of an 80 μL aliquot was
recorded at 570 nm on a BioTek Synergy 2 microplate reader. The inhibition assay of HiDapE
by lithium sulfate was performed in triplicate, and the IC50 was determined to be 13.8 ± 2.8 mM.

The IC50 and kinetics constants were obtained by fitting the data following modified Hill
equation: V = V0 + (Vmax−V0) XnH / (XnH0.5 + XnH) using the graphing suite Origin 9.1 with the
Levenberg-Marquardt non-linear least-squares algorithm.25, 26 The velocity in the absence of the
substrate is V0, the velocity at saturating concentrations of the substrate or with no inhibitor for
the inhibition assay is Vmax, X is the concentration of the substrate or inhibitor, X0.5 is the
substrate (S0.5) and inhibitor (I0.5) concentration at 50% maximum velocity and at 50% inhibition,
respectively. The Hill coefficient is represented as nH. The inhibition plot is included in the
Supplemental as Figures S3.
Kinetic studies
A discontinuous kinetic assay was performed on a Techne PCR Thermal Cycler System
utilizing a modified ninhydrin assay protocol6. The volume of each component was adjusted to
fit the total reaction volume of 50 µL and the enzyme concentration was 0.12 µM. Inhibition of
HiDapE with 10 mM, 20 mM, and 30 mM lithium sulfate was studied in triplicate while
changing the substrate concentration from 0.5 mM to 5.5 mM. The amount of N-methyl-L,LDAP formed over 10 minutes was monitored by measuring the absorbance of the complex
formed by reacting N-methyl-L,L-DAP with 2% ninhydrin. The enzymatic activity was reported
as the rate of formation of the product, N-methyl-L,L-DAP in absorbance unit per minute
(AU/min). The kinetic constants were reproducible within ± 11% using the modified Hill
equation utilizing the Levenberg-Marquardt non-linear least-squares algorithm.25
Sequence Comparisons

The non-repetitive sequence database was searched for homologs of NmDapE using the
blastp algorithm.27 The sequences for the 99 DapE proteins found were aligned using the Clustal
Omega algorithm 28
Targeted Molecular Dynamics
The starting structure for Targeted Molecular Dynamics experiments was the new PDB
5UEJ structure. The target structure used for these simulations was a homology model of the
closed structure (PDB 5VO3) that had the sequence of the open structure (PDB 5UEJ), and was
created using SwissModel.29 The two sequences were 55.1% identical, which is sufficient to
produce a good homology model.30 The structural assessment of the model using the tools
available through Swiss-Model showed that it was a high-quality model. For molecular
dynamics experiments, each simulation box containing either the open or the closed
conformation of DapE, the substrate, and the catalytic zinc ions was assembled using the
molecular graphics program VMD.24 The simulation box was then brought to equilibrium using
the molecular dynamics program NAMD.31 The equilibration procedure involved energy
minimization with and without restraints on the protein coordinates (6 ps each), slow heating
from 10 to 310 K (60 ps), and then pressure and temperature equilibration using a Langevin
piston (20 ps). Finally, unrestrained dynamics for 2 ns was done before data were acquired.
Periodic boundary conditions were used. The cutoffs for nonbonding (van der Waals and
electrostatic) interactions were 15 Å. The switch distance was 13 Å, and a 1.0 1–4 scaling factor
was used. In the TMD simulations, the force constant set for the calculations was 1000
kcal/mol/Å2. The simulation was run for a total of 50 ns. All calculations were performed using
CHARMM 36 parameters.32-35 The zinc ion in this forcefield is represented by electrostatic and
van der Waals potentials. The total interaction energy values were determined for every 0.1 ns in

each set of simulations. All molecular graphics diagrams were generated using VMD.24 The
sulfur atom coordinates from the sulfates in the crystal structure were used to assign the
coordinates of the carboxylate carbon atoms found at both ends of the substrate. The rest of the
substrate atoms were then built and the energy of the overall structure was minimized. In the
closed structure, the product positions were used as a reference for where the substrate should be
built. Once the substrate was constructed, a water box with 0.15 M NaCl was built enclosing
both DapE and the substrate to neutralize charges and mimic a physiological environment for the
enzyme and substrate. The structure was then equilibrated for 2 ns in order to allow each system
to achieve a local minimum energy conformation. TMD simulations were then run for 50 ns
using this equilibrated structure. The equilibrated structure was then re-equilibrated twice for an
additional 2 ns each. The TMD simulations were then rerun twice for 50 ns using these reequilibrated structures. The target structure used for these simulations was a homology model of
the closed structure (PDB 5VO3) that had the sequence of the open structure (PDB 5UEJ), which
was created using SwissModel.29

Results and Discussion
High-Resolution X-Ray Crystal Structure: Comparison and Flexibility of DapE Structures
As expected, the new high-resolution X-ray structure of NmDapE (PDB 5UEJ) shares
many of the aspects of previously reported HiDapE structures. HiDapE and NmDapE share a
very high sequence homology of 55 % with no sequence gaps and bear the same active site
architectures including metal binding residues and substrate binding residues necessary for
hydrolytic activity.14 Both are dimers with two domains in each chain (Figure 2A). The
catalytic domain is globular and contains two Zn2+ ions and most of the catalytic residues. The

catalytic domain in the new NmDapE open structure interacts with the communications domain
of the other subunit, but the communications domains from the two chains form most of the
inter-subunit contacts. There is a significant conformational change observed between the open
and closed forms of the enzyme, which likely occurs upon substrate binding (Figures 2A and
2B).
Comparison of three different DapE crystal structures (5UEJ, 5VO3, and 3IC1) reveals
significant differences in the orientations of the domains (Figure 2C-E). The dramatic change
from the open to the closed conformation has been noted previously,12, 36 but even the differences
in conformations of available open structures (PDB 3IC1 and 5UEJ) are also striking, and
comparison of eight different DapE structures (Figure S2) underscores the wide range of
conformational flexibility of the DapE subunits. The products-bound structure manifests a
different twist (Figure 2C) than the structures without product, and we have analyzed this change
using conformationally sensitive dihedral angles (Figures S1 and S2). Conformational
differences may also be due in part to differences in the crystallization conditions (Table S2), and
there are many examples where different domain or subunit contacts are found for the same
protein due to different crystallization conditions. For example, over 30 years ago Schiffer and
co-workers37 found that the domains of a Bence-Jones protein could adopt different domain
associations depending on the crystallization conditions. For the Bence-Jones structures, the
structural changes are limited to the way in which the domains are associated rather than to the
folding of the domains themselves, and this is also true for the DapE structures. This ability to
adopt different domain arrangements is due to the domains being connected by only one
polypeptide strand in the case of Bence-Jones protein or two strands of a polypeptide chain in the
case of DapE, allowing flexibility between domains.

Figure 2: DapE enzyme X-ray crystal structures illustrating conformational changes. (A) DapE open conformation of
NmDapE (PDB 5UEJ) with the substrate shown in blue space-filling atoms modeled in the active site; (B) closed
conformation of HiDapE (PDB 5VO3) with the bound substrate modeled in space-filling blue atoms; Panels (C), (D),
and (E) show overlap of three different DapE structures: the new high-resolution open NmDapE structure PDB 5UEJ
in red, the 2.30 Å resolution open HiDapE structure PDB 3IC1 in green, and the products-bound NmDapE structure
PDB 5VO3 in blue. The A-chains for all three proteins are superimposed on the left side of Figures 2C-E showing
the different positions of the B chains on the right side of each representation, with each panel showing mutually
perpendicular views of the three overlapped structures.

Hinge-like motions caused by different crystal environments have been seen in many
other proteins,38, 39 along with the ability of crystal packing contacts to cause these variations.40,
41

On the other hand, there are even more examples of different domain or subunit arrangements

that occur due to the binding of a ligand.42 The conformational change due to binding of the
products by DapE (PDB 5VO3 in Fig. 2B) is different than the range of flexibility seen for the
DapE structures without bound products. A significant twist in the conformation of DapE is

demonstrated by changes in selected dihedral angles (Figures S1 and S2) that are notably
different for the products-bound structure.
Inhibition of DapE by Sulfate
We observed that two sulfate ions are bound in the new open NmDapE structure (5UEJ)
and hypothesized that these sulfates from the crystallization buffer occupy the same locations
occupied by two of the negatively-charged carboxylates of the substrate. This was confirmed by
direct comparison of the products-bound HiDapE closed structure (5VO3) with the sulfate-bound
NmDapE open structure (5UEJ), where the carboxylates are observed to electrostatically bind to
Arg178 and Arg258 of HiDapE, analogous to the sulfates binding Arg179 and Arg259 of
NmDapE, respectively (Figure 3). Arginine residues were found in these positions in all of the
99 sequences similar to NmDapE found by a blastp search. Reviewing all eleven DapE
structures deposited in the PDB (summarized in Table S2), six of the crystal structures are
observed to have one or two sulfates bound in their active sites. DapE crystal structures with at
least one bound sulfate in the active sites include PDBs 3IC1 and 3ISZ,10 as well as PDBs 4O23,
4PPZ, and 4PQA.11 The DapE structure that was first reported is an apo structure, 1VGY9 that
lacks bound sulfates, although crystallization conditions were not reported, making it impossible
to know if sulfate ions were present in the crystallization solution. Several truncated DapE
proteins have been expressed lacking the linker domains and were crystallized in the presence of
acetate rather than sulfate (PDBs 4ONW, 4OP4, and 4H2K),43 and therefore do not have bound
sulfate, but neither do they exhibit bound acetate in their active sites. These truncated DapE
proteins are either missing the Arg residues that bind the sulfates, or these Arg residues are near
the new termini of the protein and thus are in very flexible regions of the structure. Therefore,
sulfate binding to these residues would not be expected. Sulfates are well known to bind at

protein phosphate sites,44, 45 and sulfate ions can also compete with carboxylate ions for binding
sites.46
Realizing that sulfate may compete with the substrate in the active site, we determined the
inhibitory potency of sulfate to be IC50 = 13.8 ± 2.8 mM using our ninhydrin-based assay
(Figure S3).6 The concentration of sulfate in the crystallization buffer of PDB 5UEJ was 1.46 M,
which is 106X higher than the IC50 of sulfate, consistent with its presence in the active site. The
only reported products-bound structure (5VO3) did not have sulfate in its crystallization buffer,
which was likely more advantageous for substrate binding given the absence of competing
sulfate. In order to investigate the nature of sulfate binding to the DapE active site we performed
a kinetic assay varying the substrate and sulfate concentrations. The sulfate inhibition of HiDapE
followed a competitive inhibition pattern as summarized in Table 1 and the saturation curves are
reported in Supplemental as Figure S4, S5, S6, S7 and S8. The saturation of activity with
increasing substrate concentration was not observed, rather the enzymatic activity was
inconsistent as the pH of the solution started to decline with increasing N-methyl-L,L-SDAP
substrate concentration above 5.5 mM. The decrease in the pH of the solution was attributed the
to the fact that N-methyl-L,L-SDAP was synthesized and used as the trifluoroacetate salt of the
amine, hence at higher concentrations it ultimately affects the pH of the solution.
Table 1: Kinetic parameters for HiDapE with N-methyl-L,L-SDAP substrate.
Assay
Control

Inhibition

Sulfate (mM)

Vmax (AU/min)

S0.5 (mM)

0

0.068 ± 0.0055

1.21 ± 0.15

10

0.073 ± 0.0072

2.50 ± 0.29

20

0.080 ± 0.0098

2.72 ± 0.066

30

0.084 ± 0.0052

2.92 ± 0.098

Figure 3. Key Coulombic interactions of (A) the terminal substrate-derived carboxylates of the products in HiDapE
(PDB 5VO3) with Arg178 and Arg259, and (B) the two bound sulfate ions in the open conformation of NmDapE
(PDB 5UEJ) with the corresponding arginine residues Arg179 and Arg259, respectively.

Targeted Molecular Dynamics
The open conformation DapE structures, including the new high-resolution structure, in
comparison with our products-bound closed X-ray crystal structure12 reveal the dynamic
conformational change between the open and closed states of DapE (Fig. 4). This conformational
change was proposed to be induced by substrate binding, which is consistent with a hinge
domain mechanism that enables both domains to interact with the substrate. The HiDapE
products-bound structure further revealed several new protein-ligand interactions that had not
been predicted by docking or by molecular dynamics47 including the demonstration of distinct
succinate and diaminopimelic acid binding pockets, and that both domains play a key role in
substrate recognition and catalysis.

To better understand the catalytically important conformational change of DapE from the
open to the closed conformer, TMD simulations were performed. TMD involves application of
an additional force on selected atoms in the direction of the positions of their counterparts in the
target structure.48, 49 This force depends on the number of atoms selected, the selected force
constant, and the RMSD between the coordinates at any given time during the simulation and the
final coordinates. Three TMD runs were performed from the open to the closed conformation
using PDB 5UEJ for the open starting DapE conformation and 5VO3 for the closed target
conformation. The selected atoms were either all the -carbons in both subunits or all the carbons in just one of the two subunits. Prior to running TMD simulations, the native substrate
L,L-SDAP was built into the active sites of both the initial and target structures and the system

was relaxed as described in the Experimental section. In the open structure, placement of the
substrate was guided by the positions of the two sulfate ions found in the active site of the PDB
file to model the positions of the substrate terminal carboxylates. Substrate was placed into the
active site of the closed structure in a manner consistent with the binding of the products in
5VO3.
The first TMD scenario applied a force to both subunits of DapE in the open conformation.
Both subunits approached the closed conformation as measured by their degree of overlap with
the target structure (Figures 4A and 4B). Furthermore, RMSD values comparing the initial
structure to the target structure were calculated before and after the simulation to

Figure 4. Images of subunit A (A) and subunit B (B) of the DapE enzyme overlaid at t = 0 (in red) and t = 50 ns (in
blue) in the simulation with the force on both subunits. The substrate is also shown in both active sites in its position
at t = 0 (in red) and t = 50 ns (in blue). Average RMSD between subunits A (in orange) and B (in green) in the open
structure and their positions in the closed structure is shown in graph (C).

determine the degree of closure. The RMSD differences by subunit show near-complete
convergence of the original open structure toward the target closed structure during each run
(Figure 4C). The second and third TMD experiments involved applying the additional force
only to subunit A, and then only to subunit B, respectively. These calculations were performed to
investigate if closing one subunit might compel the other subunit to also begin closing. In the
simulation with the force applied only to subunit A, that subunit closes as it did with the force
applied to both subunits (Figure 5A), however subunit B does not close or converge toward the
target coordinates to any significant extent (Figure 5B). The independence of the two subunits is
also supported by the change in RMSD values between the initial structure and the target
structure at the beginning and end of the simulation (Figure 5C). In the simulation with the force

applied only to subunit B, the simulation plays out in the reverse manner. Subunit B closes
completely under these conditions whereas subunit A does not converge toward the target
structure. Changes in the RMSD values between the initial and final structures support this
observation that movement was only observed in the subunit to which force was applied (Figure
S6A3).

Figure 5. (A) Images of subunit A (A) and subunit B (B) of the DapE enzyme overlaid at t = 0 (in red) and t = 50 ns
(in blue) in the simulation with the force only on subunit A. The substrate is also shown in both active sites in its
position at t = 0 (in red) and t = 50 ns (in blue). Average RMSD between subunits A (in orange) and B (in green) in
the open structure and their positions in the closed structure is shown in graph (C).

Although no force was applied to the substrate, L,L-SDAP, it moved due to its
interactions with the protein. As the subunits in the open conformation close, the substrate
becomes further enveloped within the active site, and the distance between it and the catalytic

zinc atoms decreases dramatically in both subunits in all three sets of simulations (Figure S6B13). The movement of the substrate is likely a result of the Coulombic attractions between two of
the carboxyl groups in L,L-SDAP and Arg179 and Arg259, respectively, as well as a function of
the movement of His195 from the communications domain of the opposite subunit. When
observing the initial and final positions of the substrate in all three sets of simulations, the
substrate interacts consistently with both arginine residues, while at t = 50 ns, His195 has moved
into the active site in the closed conformation, enabling its critical interaction with the substrate.
The Arg179 and Arg259 residues interact with the substrate initially (Figure 3B) and
throughout the simulation (Figures S6D1-3, S6E1-3, and S6G1-3), indicating that these arginine
residues likely play a significant role in ferrying the substrate from its initial binding site further
into the enzyme as it closes (Figures 6A and 6B). We had previously demonstrated inhibition of
HiDapE by addition of the arginine-specific chemical modification reagent 2,3-butanedione,
indicating that at least one arginine residue interacts with the substrate.12 His195B, by contrast,
is much further from the substrate but moves a significant distance (~6 Å) from the
communications domain of the opposite subunit in order to participate in the active site and form
the oxyanion hole that enables cleavage of the substrate.12 His195B moves closer to the catalytic
zinc atoms over the course of the conformational change and is in position to interact with the
active site by the end of the simulation (Figures 7A-C and S6C1-3). This motion should
contribute to an overall stabilization as the substrate moves further into the active site in the
subunits that are closing. Calculated interaction energies between the substrate and the enzyme
demonstrate that this is the case (Fig. 6C). The substrate binds more tightly as the protein closes.

Figure 6. (A) Images of the active site of DapE at t = 0 (A) and t = 50 ns (B) with the substrate and the catalytic zinc
atoms shown in the simulation with the force on both subunits. The interaction energy between the substrate and the
enzyme in subunit A (in orange) and in subunit B (in green) is shown in graph (C).

Figure 7. (A) Images of the active site of DapE at t = 0 (A) and t = 50 ns (B) with His195 and the catalytic zinc
atoms shown in the simulation with the force on both subunits. The distance from His195 to those zinc atoms in
subunit A (in orange) and in subunit B (in green) is shown in graph (C).

Conclusion

In summary, we have succeeded in crystallizing NmDapE (PDB 5UEJ), an open
conformation structure with atomic-level resolution (1.3 Å). Comparison with other DapE
structures demonstrates the flexibility of this protein. The new structure reveals two sulfates
hydrogen bound to active site Arg residues that have been implicated in substrate recognition and
binding.12 The presence of sulfate prompted us to determine the inhibitory potency of sulfate,
which has an IC50 = 13.8 ± 2.8 mM. The sulfate positions suggested the binding site for the
substrate in the open structure, and we then employed this new structure as the starting point for
our targeted molecular dynamics simulations studying the dramatic conformational change from
the open to the closed conformation that occurs when DapE binds its substrate L,L-SDAP.
Addressing the possibility that the closure of the two subunits may be linked, these TMD studies
reveal the independence of the two subunits. The TMD method enabled us to examine how
different parts of the system might affect each other. By putting a force on only one of the
subunits, we found that closing that subunit did not force the closure of the other subunit. Since
the SDAP also did not have a force on it, the results showed how the substrate is pulled into
position in the active site. Given our long-range goal of developing new antibiotics based on
inhibitors of DapE, this was an important result. The conformational change of the protein results
in the substrate moving towards the active site and increasing the binding affinity. These data
provide new insight to the proposed catalytic mechanism as they confirm the ability of DapE to
shift between an open conformation to a closed form upon the addition of substrate. They
further confirm that His195B can move more than 6 Å into the A subunit active site, a critical
step in the catalytic process. Furthmore, the design of DapE inhibitors as potential antibiotics
with a new mechanism of action is critically important. An enhanced understanding of the key
binding interactions in the active site will enable the de novo design of inhibitors as well as

optimization of existing lead structures. The sulfates bound in the active site in the new highresolution DapE crystal structure underscore the importance of the Coulombic interactions in
binding the negatively charged carboxylates in the substrate. Understanding the energetics and
geometry changes at play in the closing of the DapE subunit revealed by TMD inform the design
of potential inhibitors that can lead to a closed or partially-closed structure versus binding only to
the open conformer of DapE.
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